Non-specific immunotherapy and specific hyposensitization in severe atopic dermatitis.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D000626:Aminopeptidases / Q000037:antagonists & inhibitors*; D003078:Colchicine / Q000627:therapeutic use*; D003876:Dermatitis, Atopic / Q000276:immunology / Q000628:therapy*; D003888:Desensitization, Immunologic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007073:Immunoglobulin E / Q000032:analysis; D007930:Leucine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D014165:Transfer Factor / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D014165:Transfer Factor; D007073:Immunoglobulin E; D000626:Aminopeptidases; D007930:Leucine; C012211:ubenimex; D003078:Colchicine